300685.SZ SHZ
Amoy Diagnostics Co., Ltd.
1W: +7.1%
1M: +23.1%
3M: +20.3%
YTD: +0.5%
1Y: -8.7%
3Y: -7.2%
5Y: -59.9%
¥21.34 ($3.18)
+0.34 (+1.62%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥8.3B ($1.2B)
52W Range15.62-24.13
Volume16,871,419
Avg Volume10,149,989
Beta0.30
Dividend¥0.45
Analyst Ratings
No analyst coverage
Company Info
CEOJiemin Luo
Employees1,175
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2017-08-03
Websiteamoydx.com
39 Dingshan Road
Xiamen, FU 361027
CN
Xiamen, FU 361027
CN
86 59 2680 6835
About Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. is a Chinese company focused on oncology precision medicine. It engages in the research, development, production, and sale of molecular diagnostic products. The company provides a range of diagnostic reagents and testing services that help identify genetic mutations and biomarkers, which are used to guide personalized cancer treatment.
Latest News
No recent news
Recent Insider Trades
No insider trades found